Paroxysmal nocturnal hemoglobinuria is a rare disease in which red blood cells break down earlier than normal.
Persons with this disease have blood cells that are missing a gene called PIG-A. This gene allows a substance called glycosyl-phosphatidylinositol (GPI) to help certain proteins stick to cells. Without PIG-A, important proteins cannot connect to the cell surface and protect the cell from destructive substances in the blood. The result is a break down of blood cells. The disease can affect people of any age. It may be confused with aplastic anemia, and may turn into myelodysplastic syndrome or acute myelogenous leukemia. Risk factors, except for prior aplastic anemia, are not known.
Red and white blood cell counts and platelet counts may be low. Red or brown urine signals the breakdown of red blood cells and that hemoglobin is being released into the body's circulation and eventually into the urine. Tests that may be done to diagnose this condition may include:
Steroids or other drugs that suppress the immune system may help slow the break down of red blood cells. Blood transfusions may be needed. Supplemental iron and folic acid are provided. Blood thinners may also be needed to prevent clot formation. Soliris (eculizumab) is a new drug used to treat PNH. It blocks the breakdown of red blood cells. Bone marrow transplantation can cure this disease. All patients with PNH should receive preventative vaccinations against certain types of bacteria to prevent infection. Ask your doctor which vaccinations are right for you.
|
|
Reviewer Info: Corey Cutler, M.D., M.P.H., F.R.C.P.C, Department of Medical Oncology, Dana-Farber Cancer Institute; Instructor in Medicine, Harvard Medical School, Boston, MA. Review provided by VeriMed Healthcare Network.; ADAM Health Illustrated Encyclopedia, 03/22/2007 |